Footnotes
ID | footnote |
f1 |
represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in table i on october 8, 2019. this sale is mandated by the issuer's election under its 2005 long term incentive compensation plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
f2 |
this number includes unvested restricted stock units previously reported. |
f3 |
transaction pursuant to an existing 10b5-1 trading plan. |
f4 |
the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $122.02 to $123.00, inclusive. the reporting person undertakes to provide to haemonetics corporation ("haemonetics"), any security holder of haemonetics, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this form 4. |
f5 |
the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $123.09 to $124.02, inclusive. |
f6 |
the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $124.09 to $124.96, inclusive. |